Inflammatory bowel disease (IBD) significantly impacts patient health, with recent studies linking sarcopenia (muscle loss) to decreased quality of life and poor clinical outcomes.
An analysis of over 1.5 million hospitalizations showed that patients with sarcopenia had higher rates of in-hospital mortality (4.2% vs. 1.2%), ICU admissions, and required more surgeries compared to those without sarcopenia.
The study concludes that managing sarcopenia is essential for improving health outcomes in IBD patients, as it was associated with a nearly threefold increase in the risk of dying during hospitalization.